Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
572.60
480.72
849.60
495.05
534.25
430.01
615.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
572.60
480.72
849.60
495.05
534.25
430.01
615.66
Raw Material Cost
248.47
207.10
327.00
240.54
218.62
169.60
282.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.24
0.93
0.71
1.34
0.50
1.62
2.06
Selling and Distribution Expenses
200.69
178.64
233.59
180.67
191.66
171.91
131.57
Other Expenses
10.57
10.80
12.33
11.64
11.18
11.81
12.79
Total Expenditure (Excl Depreciation)
556.05
494.72
684.62
538.99
522.60
461.26
543.93
Operating Profit (PBDIT) excl Other Income
16.599999999999998
-14
165
-43.9
11.6
-31.200000000000003
71.7
Other Income
24.40
3.61
31.95
20.92
34.12
43.24
43.74
Operating Profit (PBDIT)
55.33
13.95
183.56
3.17
56.17
35.53
35.25
Interest
1.24
0.93
0.71
1.34
0.50
1.62
2.06
Exceptional Items
0.54
0.05
0.11
0.05
-0.60
0.61
-0.35
Gross Profit (PBDT)
324.13
273.62
522.60
254.51
315.64
260.41
333.23
Depreciation
29.75
29.75
27.73
27.73
27.39
27.39
28.24
Profit Before Tax
24.88
-16.68
155.23
-25.85
27.67
7.14
4.60
Tax
-0.51
-5.07
-8.54
-12.33
-11.28
-0.94
-28.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.39
-11.61
163.77
-13.52
38.96
8.07
33.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.39
-11.61
163.77
-13.52
38.96
8.07
33.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
25.39
-11.61
163.77
-13.52
38.96
8.07
33.41
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,016.45
3,263.40
3,262.49
3,119.15
3,115.51
3,124.52
3,108.22
Earnings per share (EPS)
0.06
-0.03
0.38
-0.03
0.09
0.02
0.08
Diluted Earnings per share
0.06
-0.03
0.38
-0.03
0.09
0.02
0.08
Operating Profit Margin (Excl OI)
0.21%
-4.04%
14.58%
-9.19%
-1.0%
-8.16%
-5.97%
Gross Profit Margin
9.54%
2.72%
21.54%
0.38%
10.31%
8.03%
5.33%
PAT Margin
4.43%
-2.42%
19.28%
-2.73%
7.29%
1.88%
5.43%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 7.17% vs 0.17% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -34.87% vs -44.60% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 39.82% vs -46.75% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 140.00% vs -68.75% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Sonoscape Medical Corp. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
572.60
0
572.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
572.60
0
572.60
Raw Material Cost
248.47
0
248.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.24
0
1.24
Selling and Distribution Expenses
200.69
0
200.69
Other Expenses
10.57
0.00
10.57
Total Expenditure (Excl Depreciation)
556.05
0
556.05
Operating Profit (PBDIT) excl Other Income
16.55
0.00
16.55
Other Income
24.40
0
24.40
Operating Profit (PBDIT)
55.33
0
55.33
Interest
1.24
0
1.24
Exceptional Items
0.54
0
0.54
Gross Profit (PBDT)
324.13
0
324.13
Depreciation
29.75
0
29.75
Profit Before Tax
24.88
0
24.88
Tax
-0.51
0
-0.51
Provisions and contingencies
0
0
0.00
Profit After Tax
25.39
0
25.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
25.39
0
25.39
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
25.39
0
25.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,016.45
0
3,016.45
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
0.21%
0%
0.00
0.21%
Gross Profit Margin
9.54%
0%
0.00
9.54%
PAT Margin
4.43%
0%
0.00
4.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 57.26 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 19.12% vs -43.42% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 7.17% vs 0.17% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.54 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 318.97% vs -107.08% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -34.87% vs -44.60% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.09 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 200.00% vs -93.21% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 39.82% vs -46.75% in Jun 2025
Quarterly - Interest
Interest 0.12 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 33.33% vs 28.57% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 140.00% vs -68.75% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.21%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
